Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

FDA approves Otezla for the oral treatment of plaque psoriasis

Sep. 25, 2014

Sun Pharma and Merck & Co. form licensing agreement for tildrakizumab

Sep. 18, 2014

Dovobet ointment launched in Japan

Sep. 12, 2014

Synergistic activity of neem, karanja and aloe vera in patients with skin injuries

Sep. 4, 2014

Birken reports results from phase III trials of Oleogel-S10 for partial thickness wounds

Sep. 2, 2014

Adocia launches phase III study of BioChaperone PDGF-BB in diabetic foot ulcers

Aug. 27, 2014

NFkB decoy oligonucleotide moves to phase III study in atopic dermatitis

Aug. 26, 2014

Auxilium and BioSpecifics report positive data from phase IIa trial of Xiaflex

Aug. 22, 2014

Lilly's ixekizumab superior to etanercept in phase III plaque psoriasis trials

Aug. 22, 2014

Covance to conduct phase I/II study of AM-1030 in atopic dermatitis

Aug. 20, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...